Number of the records: 1  

Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: In vitro effect of extra drug-free GlyPheLeuGly sequences

  1. 1.
    ŘÍHOVÁ, B., STROHALM, J., HOVORKA, O., ŠUBR, V., ETRYCH, T., CHYTIL, P., POLA, R., PLOCOVÁ, D., BOUČEK, J., ULBRICH, K. Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: In vitro effect of extra drug-free GlyPheLeuGly sequences. Journal of Controlled Release. 2008, 127(2), 110-120. ISSN 0168-3659. E-ISSN 1873-4995. Available: doi: 10.1016/j.jconrel.2008.01.003
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.